Home/ Supplements/ Vitamin K/ Vitamin D Supreme with Vitamin K1 and K2

Vitamin D Supreme with Vitamin K1 and K2

product on market Capsule Designs for Health Safety: 80/100
80/100

This product is generally safe

  • Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin D and K are supported by strong evidence for maintaining bone density and supporting calcium homeostasis. Research indicates that combining these nutrients may improve calcium absorption and cardiovascular health. The evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)

Label

Product Label

Label for Vitamin D Supreme with Vitamin K1 and K2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

5000 IU (1250% DV)
Exceeds UL by 1.2× (UL: 0.1 mg) 608 studies (A:16, B:251)
550 mcg (688% DV)
4.6× RDA — above typical dose 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Cellulose L-Leucine
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Recommended use: As a dietary supplement, take one capsule per day with a meal, or as directed by your health care practitioner.

Warnings & Precautions

Report any adverse reactions to 860-623-6314

Warning: Consult your health care practitioner before taking this product if you are taking Coumadin, warfarin or other anticoagulant medications.

Keep out of reach of children.

Formulation Notes

Does not contain gluten.

Vitamin D Supreme with Vitamin K1 and K2

Made with Non-GMO ingredients

Additional Information

For professional use only

Guaranteed GMP compliant products Made with Non-GMO ingredients

Manufactured in a GMP Registered Facility in the USA

Notice: Color, size or shape may appear different between lots.

Store at room temperature.

Metadata

Product Details

UPC / SKU8 79452 00191 6
DSLD Entry Date2019-10-23
Product TypeVitamin
FormCapsule
BrandDesigns for Health
DSLD ID208599
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Designs for Health View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.